- Home
- ARTNA vs AVIR Comparison
ARTNA vs AVIR Comparison
Compare ARTNA & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARTNA | AVIR |
|---|---|---|
| Founded | 1905 | 2012 |
| Country | United States | United States |
| Employees | 274 | N/A |
| Industry | Water Supply | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 399.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARTNA | AVIR |
|---|---|---|
| Price | $34.16 | $4.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 30.3K | ★ 365.4K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | $7.82 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | $15.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.50 | $2.78 |
| 52 Week High | $34.90 | $6.45 |
Technical Indicators
Market Signals| Indicator | ARTNA | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 55.20 |
| Support Level | $31.87 | $4.14 |
| Resistance Level | $34.86 | $5.04 |
| Average True Range (ATR) | 0.74 | 0.23 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 44.37 | 72.52 |
Price Performance
Historical ComparisonAbout ARTNA Artesian Resources Corporation
Artesian Resources Corp operates as a holding company based in the United States. Through its subsidiaries, it offers water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The Group distributes and sells water, including water for public and private fire protection, to residential, commercial, industrial, municipal, and utility customers. Additionally, it is involved in contract water and wastewater operations; offers wastewater services, and water, sewer, and internal Service Line Protection Plans. The Group operates its businesses mainly through one reportable segment, the Regulated Utility segment.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.